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The APP intracellular domain forms nuclear multiprotein
complexes and regulates the transcription of its own
precursor
Abstract
The physiological functions of the beta-amyloid precursor protein (APP) may include nuclear
signaling. To characterize the role of the APP adaptor proteins Fe65, Jip1b, X11alpha (MINT1)
and the chromatin-associated protein Tip60, we analyzed their interactions by confocal
microscopy and co-immunoprecipitations. AICD corresponding to S3-cleaved APP bound to
Fe65 that transported it to nuclei and docked it to Tip60. These proteins formed
AICD-Fe65-Tip60 (AFT) complexes that were concentrated in spherical nuclear spots.
gamma-Secretase inhibitors prevented AFT-complex formation with AICD derived from
full-length APP. The APP adaptor protein Jip1b also transported AICD to nuclei and docked it
to Tip60, but AICD-Jip1b-Tip60 (AJT) complexes had different, speckle-like morphology. By
contrast, X11alpha trapped AICD in the cytosol. Induced AICD expression identified the
APP-effector genes APP, BACE, Tip60, GSK3beta and KAI1, but not the Notch-effector gene
Hes1 as transcriptional targets. These data establish a role for APP in nuclear signaling, and
they suggest that therapeutic strategies designed to modulate the cleavage of APP affect
AICD-dependent signaling.
Introduction
The amyloid precursor protein (APP) is a single-pass
transmembrane protein that is involved in the pathophysiology
of Alzheimer’s disease (AD) (Selkoe, 1999). Successive
proteolytic processing, with ectodomain shedding followed by
intramembraneous cleavage (De Strooper, 2003; Sisodia and St
George-Hyslop, 2002; Walter et al., 2001), generates beta-
amyloid (Ab ) peptides; these aggregate to form b -amyloid
plaques in the brains of patients with AD. A large body of
genetic and cell biological evidence strongly argues for
pathogenic activities of Ab , including a role in the formation
of neurofibrillary tangles (Gotz et al., 2001; Lewis et al., 2001).
Initial clinical evidence in support of a pathogenic role of A b
in humans was recently provided by the observation that
antibodies against Ab generated in response to vaccination
slowed the rate of cognitive decline in patients with AD (Hock
et al., 2002; Hock et al., 2003). Together, these findings led to
the development of a large variety of different pharmacological
and immunological approaches aiming at lowering brain levels
of Ab . Along with A b generation, intramembraneous
proteolysis of APP also liberates the APP intracellular C-
terminus (AICD) from the membrane. AICD was described
long after the initial identification of APP (Passer et al., 2000),
probably because of its rapid degradation after release from the
membrane into the cytoplasm (Cupers et al., 2001a; Kimberly
et al., 2001), in part by insulin degrading enzyme (Edbauer et
al., 2002; Farris et al., 2003).
The analogy of APP processing to Notch receptor signaling
suggested a possible function for AICD in nuclear signaling
(De Strooper et al., 1999; Schroeter et al., 1998). In a seminal
experiment, Cao and Südhof (Cao and Südhof, 2001) have used
APP- and AICD-fusions with the yeast Gal4 transcription
factor DNA-binding domain and observed transactivation
activity for AICD. This was dependent on the APP-adaptor
protein Fe65 (Duilio et al., 1991; Minopoli et al., 2001) and
the Fe65-binding nuclear histone acetylase Tip60 (Sterner and
Berger, 2000). However, the possibility remains that, in
transient transfection assays, the transcription from reporter
constructs could also occur in the cytosol. Fe65 has been shown
to stabilize the intracellular domains of g -secretase cleaved
APP, APLP1 and APLP2, which together with Fe65, localized
to the nuclear compartment (Kimberly et al., 2001; Walsh et
al., 2003). These experiments suggested a role in nuclear
signaling for the AICD.
To characterize the molecular requirements for the nuclear
localization of AICD, we used inducible expression of
fluorescently tagged AICD and cotransfection of AICD-
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bovine serum (Gibco, Basel, Switzerland). Transfections were done
with Lipofectamin 2000 (Invitrogen, Basel, Switzerland) either on
plastic culture dishes or on glass slide chambers (Falcon,
Mettmenstetten, Switzerland) coated with polyornithine (10 m g/ml,
Sigma, Buchs, Switzerland) and laminin (5 m g/ml, Invitrogen, Basel,
Switzerland). For all experiments involving confocal microscopy cells
were fixed with 4% paraformaldehyde in PBS 16 to 20 hours after
transfection. At this time expression levels of transfected Fe65 were
threefold higher than endogenous levels and transfected Tip60 led to
a fivefold increase over expression in naive HEK293 cells as
determined by western blotting. In experiments involving stable lines
with inducible expression of citrine-AICD, the expression was
induced the day before transfection, resulting in expression for 40 to
44 hours. In long-term experiments we observed no evidence of
toxicity or apoptosis, as determined by TUNEL staining (Kit 1 684
817, Roche, Rotkreuz, Switzerland), for up to 5 days of induced
expression of citrine-AICD. To inhibit g -secretase either 1 m M DAPT
or 10 m M L685,458 (Calbiochem, Lucerne, Switzerland) were added
after transfection. SH-SY5Y neuroblastoma cells were grown in
DMEM/F12 supplemented with 20% fetal bovine serum. For
differentiation, cells were sequentially treated for 5 days with 5 m M
retinoic acid (Sigma, Buchs, Switzerland) and for 5 days with 20
ng/ml BDNF (Peprotech, London, UK), with serum reduced to 2%,
after which they were transfected identically to HEK293 cells.
Expression constructs
To construct an inducible expression vector we excised the Bombyx
mori ecdyson receptor-VP16 fusion transactivator and response
elements from a retroviral backbone (Suhr et al., 1998) and cloned
them into plasmids with inverted repeats recognized by the sleeping
beauty transposase (Ivics et al., 1997). Expression of the Bombyx
transactivator was driven by a glyceraldehyde-3-phosphate
dehydrogenase promotor excised HindIII/XbaI from a plasmid
provided by Maria Alexander (Harvard Medical School, Cambridge,
MA) (Alexander et al., 1988). The ecdyson response element was
followed by a polylinker for the insertion of citrine-AICD and APP-
citrine fusion proteins. The improved YFP citrine (Griesbeck et al.,
2001) was a gift from R. Y. Tsien (University of California at San
Diego, CA). For the citrine-AICD fusion protein, the C-terminal lysine
of citrine was followed by a GPGAL spacer fused to valine50 (Ab
sequence) of the S3-cleaved APP C-terminal domain. For full-length
APP, citrine was fused to the C-terminus of APP695, either via a short
spacer (APP-PGPRASLPVAT-citrine), or via a dual tandem HA tag
(APP-PGPRSGYPYDVPDYATGYPYDVPDYATGDP-citrine).
Mouse Jip1b and human X11a with an N-terminal HA tag in
pcDNA3.1 have been described previously (Taru et al., 2002a; Taru
and Suzuki, 2004). Human Fe65 with an N-terminal HA tag in
pcDNA3.1 was a gift from Konrad Beyreuther (ZMBH, Heidelberg,
Germany). We exchanged the HA tag for myc or FLAG tags in Fe65
and Jip1b for some experiments. A CFP-Tip60 (human Tip60) fusion
protein in pEGFP-C2 (Clontech, Basel, Switzerland) was provided by
Craig Robson (Northern Institute for Cancer Research, Newcastle,
UK) (Gaughan et al., 2001) and the GFP was substituted by CFP via
NheI and BsrGI sites. Site-directed mutagenesis (Quick Change
Mutagenesis Kit, Stratagene, Amsterdam, The Netherlands) was
performed to mutate the NKSY of Tip60 to NASA. All cloned and
mutagenised constructs were verified by sequencing (ABI Prism 310,
Perkin Elmer, Hühnenberg, Switzerland).
Staining and antibodies
Primary antibodies were anti-HA tag, high affinity (Roche, Rotkreuz,
Switzerland), anti-APP C-terminus (8717, Sigma, Buchs,
Switzerland), 6E10 (Signet, Dedham, MA), 22C11 (MAB348,
Chemicon, Lucerne, Switzerland), anti-Fe65 (sc-19751, Santa Cruz,
Nunningen, Switzerland), anti-Jip1, 2 (34-5300, Zymed, Basel,
Switzerland), anti-GAPDH (A6457, Molecular Probes, Lucerne,
Switzerland), anti-Tip60 (Upstate, Lucerne, Switzerland), anti-myc
tag (Upstate, Lucerne, Switzerland), anti-FLAG tag (Sigma, Buchs,
Switzerland) and anti-GFP (Upstate, Lucerne, Switzerland). All
washings were performed with TBS, 0.05% TritonX-100, for blocking
and antibody incubation 5% normal horse and 5% normal goat serum
were added. All secondary antibodies were highly purified for species
cross-reactivity (Jackson Labs, Bar Harbor, Maine) labeled with Cy3
or Cy5 dyes. In control experiments, omitting the respective primary
antibody showed no staining of antibodies from other species. For
nuclear staining we used DRAQ5 (Biostatus, Leicestershire, UK),
which is an anthraquinone that has a high affinity for DNA, can be
excited by the 633 nm laser line, and emits in the far red spectrum.
Confocal microscopy and fluorescence resonance energy
transfer (FRET) analysis
All images were acquired on a Leica TCS/SP2 confocal microscope
(Leica, Wetzlar, Germany) with a 63· water immersion objective. The
Argon Laser line of 458 nm was used to excite CFP (PMT window:
465-485 nm) and the 514 nm line to excite citrine. The PMT window
for detecting citrine was 525-580 nm when co-stained with Cy5, and
525-545 nm when co-stained with Cy3 to prevent the detection of Cy3
in the citrine channel. A 543 nm HeNe laser was used to excite Cy3
(PMT window: 553-600 nm). A 633 nm HeNe laser was used to excite
Cy5 (PMT window: 655-710 nm) or DRAQ5 (PMT window: 650-800
nm). Between 5 and 15 sections in the z-axis (xy-mode) or y-axis (xz-
mode) were acquired, and maximum projections of the sections
encompassing the nucleus were performed.
Raw FRET was measured by exciting CFP with the 458 nm laser
line and measuring sensitized citrine emission at 525-555 nm in single
sections. Values for CFP bleach-through (0.24) and citrine cross-
excitation (0.07) were determined in cells expressing either fluorophore
alone. No pixel shift was observed and background fluorescence was
negligible. After sequentially measuring raw FRET, CFP and citrine
fluorescence NFRET calculations were performed as described
previously (Xia and Liu, 2001). For bleaching experiments the image
was zoomed four- to sixfold and the citrine fluorescence in single nuclei
was bleached with the 514 nm line at 100% laser intensity.
Western blotting and immunoprecipitation
Stably transfected HEK293 cells were induced to express citrine-
AICD, and were cotransfected with Fe65 or Tip60 expression
constructs. For the preparation of nuclear protein extracts, cells were
collected in hypotonic buffer 24 hours after cotransfection [10 mM
Hepes, 10 mM KCl, 5 mM MgCl2, 1 mM DTT, 1 mM PMSF, 2.5 ·
Roche Complete protease inhibitor mix without EDTA (Roche,
Rotkreuz, Switzerland), 5 mM phenantroline (PNT) (Sigma, Buchs,
Switzerland)], swollen on ice for 15 minutes and passed through a 22
G syringe. Sucrose was added to a final concentration of 0.25 M
followed by centrifugation for 5 minutes at 500 g.
Pellets were resuspended in wash buffer (25 mM sucrose pH 7.5,
6 mM MgCl2, 10 mM TrisHCl (pH 7.4), 0.1% TritonX-100, 1 mM
PMSF, 5 mM PNT, 2.5 · Roche Complete without EDTA) and
centrifuged again at 500 g (repeated twice). Nuclei were solubilized
for 1 hour in wash buffer supplemented with 1% TritonX-100 and
mechanically disrupted by passing through a 26 G syringe.
Nuclear protein extracts were incubated over night at 4°C with
specific antibodies coupled to protein G sepharose (Amersham,
Otelfingen, Switzerland) in the presence of 0.2% TritonX-100.
Precipitated proteins were washed and boiled in LDS-containing
loading buffer, separated by 4-12% Nupage Tris-PAGE (Invitrogen,
Basel, Switzerland) with MOPS running buffer. Blotting onto PVDF
membranes (Invitrogen, Basel, Switzerland) was followed by enhanced
chemiluminescense detection (Amersham, Otelfingen, Switzerland) or
SuperSignal West Femto (Pierce, Lausanne, Switzerland).
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Whole cell extracts from HEK293 were isolated in a PBS lysis
buffer containing 1% Triton X-100, supplemented with 1 mM PMSF
and Roche Complete Protease inhibitor mix with EDTA (Roche,
Rotkreuz, Switzerland). Extracts were separated on 10-20% Tricine
gels (Invitrogen, Basel, Switzerland), blotted on nitrocellulose
membranes (0.45 m m; Biorad, Reinach, Switzerland) or Protran BA
79 Cellulosenitrate membranes (0.1 m m; Schleicher & Schuell,
Dassel, Germany) and detected by enhanced chemiluminescence as
above.
Reverse transcription (RT) and quantitative real-time PCR
Total RNA was isolated from clonal HEK293 lines with TRIzol
(Invitrogen, Basel, Switzerland). Cells were grown either with or
without the induction of citrine-AICD expression for 48 hours. First-
strand cDNA synthesis was performed using the SuperScript First-
Strand Synthesis System for RT-PCR (Invitrogen, Basel, Switzerland)
according to the manufacturer’s protocol. Real-time-PCR was
performed on the TaqMan using SYBR Green (Applied Biosystems,
Rotkreuz, Switzerland). The amplification mixtures contained 0.8
ng/m l Template cDNA, 1· SYBR Green PCR buffer, 3 mM MgCl2,
1.25 mM dNTPs, 0.25 U AmpErase, 0.75 U AmpliTaq Gold, 10 m M
Forward Primer and 10 m M Reverse Primer. The Primers were
designed to amplify the 3 ¢ end to middle of the ORF part, except for
the citrine-AICD fusion protein where they spanned the fusion border.
Primer sequences are: GAPDH (sense: TGGGCTACACTGAG-
CACCAG; reverse: CAGCGTCAAAGGTGGAGGAG), PGK
(sense: TGAAGGACTGTGTAGGCCCAG; reverse: TTCTTCCTC-
CACATGAAAGCG), KAI1 (sense: CTACAACAGCAGTCGC-
GAGG; reverse: CGCAGCACTTCACCTGAGC), GSK3 b (sense: A-
CAAGGACGGCAGCAAGGT; reverse: ACTTCTTGTGGCCTG-
TCTGG), APP (sense: ACCAACTTGCATGACTACGGC; reverse:
CACACAAACTCTACCCCTCGG) ADAM10 (sense: CTCCAC
AGCCCATTCAGCA; reverse: GCGTCTCATGTGTCCCATTTG)
BACE (sense: AGTCATCCACGGGCACTGTT; reverse: CT-
GAACTCATCGTGCACATGG), PSEN1 (sense: CTATAGCTCCCA-
TGGCACCC; reverse: CTGAACCCGCCATCATCATT), Fe65
(sense: GAGAGTGTCGGGTGCGTTTC; reverse: TGAATGCAAA-
CGTGTGGACAT) Tip60 (sense: TGAGGACTCCCAGGACAGCT;
reverse: TCGTGGCTTCGATCAGACAC) Hes1 (sense: ACGT-
GCGAGGGCGTTAATAC; reverse: CATGGCATTGATCTGGGT-
CA) citrine-AICD (sense: CACTCTCGGCATGGACGAG;
reverse: CGTCAACCTCCACCACACC). Real-time-PCR was
performed with an ABI PRISM 7700 Sequence Detector (Applied
Biosystems, Rotkreuz, Switzerland). The cycling conditions
comprised a 2 minute pre-PCR at 50°C, 10 minutes polymerase
activation at 95°C and 40 cycles at 95°C for 15 seconds and 60°C for
60 seconds. Sequence Detection Software (version 1.9.1) (Applied
Biosystems, Rotkreuz, Switzerland) was used for data analyses.
Results
Localization of AFT-complexes to nuclear spots
An experimental difficulty in monitoring the subcellular
trafficking of AICD is associated with its rapid degradation
after g -secretase cleavage (Cupers et al., 2001a; Kimberly et
al., 2001). To overcome this difficulty, we constructed
ecdyson-inducible expression vectors (Suhr et al., 1998) to
express citrine-AICD fusion proteins comprising the 50 C-
terminal residues of S3-cleaved APP. The fusion of citrine to
the N-terminus of AICD may alter its properties; specifically
we observed that citrine stabilizes the normally rapidly
degraded AICD. The inducible expression vectors were
flanked by inverted repeats for stable transfection with the
sleeping beauty transposase system (Ivics et al., 1997). After
inducing the expression of AICD with the ecdyson analogue
tebufenozide in three isolated clonal lines identified by
fluorescent microscopy, we found no evidence for
degradation of the fusion protein on western blots (data not
shown). Citrine fluorescence detected in the microscope
therefore tracks the subcellular localization of the expressed
AICD. Confocal analyses showed that AICD was localized
homogenously in both cytosolic and nuclear compartments
(Fig. 1A). The effect of APP-interacting proteins on AICD
localization was analyzed with a Fe65 isoform containing the
mini-exon 9, which has been shown to be expressed
exclusively in neuronal cells (Hu et al., 1999). When we co-
expressed AICD with Fe65 the two proteins localized both in
cytosolic and nuclear compartments (Fig. 1B). Fe65 was
described to be localized predominantly in nuclei in COS and
H4 cells (Kimberly et al., 2001; Kinoshita et al., 2002;
Minopoli et al., 2001). In HEK293 cells, nuclear
accumulation was only seen after blockade of nuclear export
(Fig. 3). Tip60 is a histone acetylase involved in many
transcriptional signals via the modification of chromatin
(Brady et al., 1999; Gaughan et al., 2001; Sterner and Berger,
2000). In the absence of Fe65, the CFP-Tip60 fusion protein
was localized in nuclear structures with a speckle-like
appearance (mean number=16.1, s.d.=6.8, median=14, n=29
cells, Fig. 1C). This localization of Tip60 had no effects
whatsoever on the cellular distribution of AICD (Fig. 1D),
suggesting that AICD did not bind to Tip60 in the absence of
Fe65. By contrast, co-expression of Fe65 clearly resulted in
binding to Tip60, and colocalization within circumscribed
nuclear spots (Fig. 1E) with a distinct spherical geometry,
clearly differing from the speckle-like morphology of the
structures that included Tip60 alone. Expression of AICD in
cells that co-expressed Fe65 together with Tip60 revealed a
striking colocalization of AICD with Fe65 and Tip60 (AFT-
complex) in these spherical nuclear spots, together with a
drop in cytosolic AICD levels (Fig. 1F). This was observed
consistently in virtually every cell co-expressing all three
proteins (Fig. 1G). The mean diameter of AFT-complexes
was 0.70 m m (s.d.=0.24, n=48 spots) and for Tip60 expressed
alone the minimal diameter averaged at 1.77 m m (s.d.=0.45,
n=49 spots). On average, we observed 32.0 nuclear spots with
AFT-complexes (s.d.=20.8, median=25, n=32 cells).
Mutation of the NKSY sequence of Tip60 to NASA, shown
to prevent AICD-mediated transactivation in the Gal4 system
(Cao and Südhof, 2001), still resulted in binding of Fe65-
AICD-complexes to nuclear Tip60, but the formation of
spherical spots was completely prevented (Fig. 1H). By
contrast, the AFT-complexes formed with NASA-Tip60 had
a speckle-like morphology. The change from spots to speckle-
like morphology of AFT-complexes may be associated with
the known functional changes of the Tip60 NASA mutation
(Cao and Südhof, 2001).
Molecular association of AICD with the histone
acetylase Tip60 in the presence of Fe65
To verify the molecular association of Tip60 and AICD in the
AFT-complex, we performed fluorescence resonance energy
transfer (FRET) measurements in cells with nuclear AICD-
spots. We followed described FRET protocols (Gordon et al.,
1998; Xia and Liu, 2001) to calculate the sensitized emission
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of citrine-AICD after excitation of CFP-Tip60 (Fig. 2A). FRET
was measured in 172 nuclear spots in 16 different nuclei, and
an average NFRET value of 0.322 (s.d.=0.181) was calculated.
The co-expression of CFP and citrine tagged with a nuclear
localization sequence resulted in strong nuclear signals from
both fluorophores, but only a marginal FRET signal (Fig. 2B)
(Average NFRET=0.066, s.d.=0.012, n=9 nuclei). This
NFRET value is higher than described for values with no
existing FRET (Xia and Liu, 2001), probably due to dense
packing of CFP and citrine in the nuclear compartment, which
leads to molecular encounters; however, it is still fivefold lower
than for FRET from CFP-Tip60 to citrine-AICD. In cells
showing sensitized emission of citrine-AICD (Fig. 2C) we also
measured increased CFP-Tip60 fluorescence after bleaching of
the citrine-AICD acceptor (Fig. 2D). The graphs show the
change in mean CFP-fluorescence from pre- to post-bleach in
individual spots. Unquenching of donor fluorescence was
measured for all bleached nuclear spots, confirming the close
molecular association of Tip60 and AICD, whereas unbleached
spots had identical or diminished fluorescence (post-/pre-
bleach ratio of 38 bleached spots: mean=1.114, s.d.=0.036;
ratio of 40 unbleached spots: 1.001, s.d.=0.032; t-test
P<0.001).
For a further support of the molecular interaction of AICD,
Fe65 and Tip60 in the nucleus, we performed
immunoprecipitations from nuclear fractions. Antibodies
directed against both AICD and Tip60 are able to pull down
Fe65 in cells expressing all three proteins (Fig. 2E).
Precipitation with an antibody against AICD also enriches for
Tip60, as shown by an antibody recognizing the CFP fused to
Tip60, with more Tip60 pulled down when Fe65 is co-
expressed. Although nuclear citrine-AICD can be imaged in
the confocal microscope (Fig. 1A) it is not detectable by
immunoprecipitation from nuclear fractions in the absence of
co-expressed Fe65. Expression of Fe65, together with Tip60
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Fig. 1. Confocal sections through nuclei show that AFT-complexes
of AICD, Fe65 and Tip60 are localized to spherical nuclear spots.
(A,B) Both AICD (yellow) and Fe65 (red) localized homogenously
throughout nuclear (blue) and cytosolic compartments in transfected
HEK293 cells. Co-expression of Fe65 and AICD resulted in the
same localization. (C) In the absence of AICD and
Fe65 co-expression, the histone acetylase Tip60
(cyan) localized to speckle-like nuclear structures.
(D) In the absence of Fe65 co-expression, Tip60
had no effect on AICD distribution. (E) In the
absence of AICD, Fe65 colocalized with Tip60 in
nuclei and reorganized the speckle-like
morphology into spherical nuclear spots. (F,G) In
cells co-expressing AICD,
Fe65 and Tip60, AICD was
relocalized from the cytosol
into AFT-complexes
predominantly found in
spherical nuclear spots. AFT-
complexes were found
throughout nuclei in all cells
co-expressing the three
proteins. Confocal xz sections of the same nuclei
confirmed nuclear localization. (H) The NASA
mutant of the putative Fe65-binding motif NKSY
in Tip60 ineffectively localized some Fe65 and
AICD to speckle-like nuclear structures, but
completely abolished the formation of spherical
nuclear spots. Bar, 10 m m.
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leads to depletion of AICD from the cytosol and accumulation
in nuclear spots (Fig. 1E,F), resulting in much higher nuclear
levels of AICD, now detectable by immunoprecipitation.
Alternatively, it is possible that free nuclear AICD, as seen in
Fig. 1A, diffuses out of the nuclei during the preparation of
nuclear fractions. AICD bound to a Tip60/Fe65-containing
complex, which might be associated with chromatin, would not
be washed away during the purification of nuclear fractions.
After precipitation with antibodies against Tip60, the GFP
antibodies also detect the citrine-AICD fusion protein, again
only when Fe65 is cotransformed. The lower band in Fig. 2E,
panel 4, is unspecific, resulting from the detection of the
antibody used for immunoprecipitation by the secondary
antibody used in western blots.
Active nuclear export of Fe65 is consistent with a
function as a shuttle for AICD
To determine if Fe65 was actively cycling between
nuclei and the cytosol, we blocked nuclear export by
leptomycin B (Ni et al., 2001). After 9 hours of blocked
export, Fe65 accumulated in nuclei (Fig. 3A). We
measured the mean fluorescence intensity of nuclear and
extranuclear compartments, as determined by DRAQ5
staining, after 24 hours of leptomycin B treatment. In
control cells, the ratio of nuclear to extranuclear intensity
measured in single confocal sections was 1.20
Fig. 2. Both FRET and immunoprecipitation reveal a close
molecular association of Tip60 and AICD in AFT-complexes.
(A) Two cells with nuclear AFT-complexes. Sensitized
emission of citrine after excitation of cyan fluorescent protein
(CFP) was calculated from raw FRET values with correction
for CFP bleach-through and citrine cross-excitation. To
prevent quenching of citrine emission, Fe65 was labeled with
a Cy5-conjugated antibody (data not shown). (B) Control cells
co-expressing CFP and citrine targeted to the nucleus with
nuclear localization signals showed very little sensitized
emission of citrine. (C) FRET measurements of AFT-
complex-containing spherical nuclear spots showed sensitized
emission from citrine-AICD in the absence of the Cy5-
conjugated antibodies against Fe65. (D) Citrine-AICD was
bleached in one nucleus and the intensity of CFP measured in
single spots before (pre) and after bleaching (post). The
graphs show the mean pixel intensity
of the measured CFP-fluorescence.
The pre/post values of single spots
are connected by a line. After
bleaching, CFP fluorescence
intensities increased in spots in the
bleached nucleus, but not in
surrounding spots in unbleached
nuclei. Bar, 10 m m.
(E) Immunoprecipitation (IP) of
AFT-complex components from
nuclear fractions. Antibodies against
AICD or Tip60 co-precipitate Fe65
as detected by western blot (WB) of
the HA tag. IP with antibodies
against AICD precipitated Tip60
and, vice versa, antibodies against
Tip60 precipitated AICD, as shown
by staining with an antibody against
fluorescent proteins that detects both
CFP and citrine. The lower band in
panel 4 is unspecific, and results
from the detection of the antibody
used for immunoprecipitation by the
secondary antibody used in western
blots. Marker proteins are 19, 28, 39,
51, 64, 97 and 191 kDa.
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(s.e.m.=0.06, n=35 cells). Leptomycin B treatment increased
this ratio to 2.65 after 24 hours (s.e.m.=0.30, n=35 cells, t-test
P<0.001, Fig. 3B). A similar increase was found for AICD,
which changed from a nuclear/extranuclear intensity ratio of
0.76 (s.e.m.=0.04, n=35 cells) to 1.84 (s.e.m.=0.29, n=35
cells). In most of the Fe65-expressing cells we also observed
the accumulation of AICD in nuclear spots after the inhibition
of nuclear export (Fig. 3A), an observation we never made in
cells co-expressing AICD and Fe65, and with intact nuclear
export. In cells showing nuclear AICD spots we did not
Journal of Cell Science 117 (19)
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observe Fe65 enriched in these spots. This could be due to the
general distribution of Fe65 in the nucleus, leading to less
distinct labeling of spots. In addition, Fe65 is detected by
antibody staining, which might differ in the multiprotein-
complex-containing spots, whereas AICD is directly detected
via the fused fluorescent protein. Cells expressing only AICD
and treated with leptomycin B had no significant change in the
ratio of nuclear-to-extranuclear intensity (control=1.74,
s.e.m.=0.06; 24 hours leptomycin B=1.50, s.e.m.=0.05, n=35
cells each, Fig. 3B). Furthermore, we never observed nuclear
AICD-spots after leptomycin B treatment in the absence of
Fe65 co-expression.
We further treated cells co-expressing AICD and Fe65 with
leptomycin B for 9 or 24 hours and prepared nuclear and
postnuclear supernatant (PNS) fractions. Western blot analysis
of Fe65 (Fig. 3C) again showed an increasing nuclear/PNS
ratio with increasing time of inhibited nuclear export.
Compared with intact nuclear export, the nuclear/PNS ratio
increased to 247% after 9 hours and to 527% after 24 hours of
leptomycin B treatment.
Regulation of AICD-effector genes
We isolated RNA populations from clonal cells with or without
48 hours of AICD induction. To determine whether inducible
expression of AICD actually results in the regulation of the
transcription of target genes, we performed real-time PCR
experiments with genes coding for proteins involved in APP
processing (ADAM10, BACE, PSEN1) or signaling (Fe65,
Tip60). In addition, we analyzed the expression of KAI1 and
GSK3 b , described candidate target genes of AICD (Baek et al.,
2002; Kim et al., 2003). The increase in citrine-AICD
transcripts after 48 hours of induction was 17.4 fold
(range=±3.2, data not shown). We detected significantly
increased transcript levels for APP, BACE and Tip60, as well
as confirmed the regulation of KAI1 and GSK3b , 48 hours after
the induction of AICD expression (Mann-Whitney U, P<0.05,
Fig. 3D). ADAM10, PSEN1 and Fe65 showed no regulation by
AICD (Fig. 3E). The induction of AICD did not affect the
expression of Hes1, a Notch-effector gene regulated by NICD
(Ohtsuka et al., 1999). Normalizations were performed with
GAPDH and PGK, yielding similar results. To judge variation,
PGK is also plotted against GAPDH.
The fact that AICD regulates the transcription of its
precursor prompted us to test whether protein levels of APP
are also upregulated. We induced AICD-citrine expression for
48 hours in clonal HEK293 lines. Staining with antibody 6E10,
which stains the A b -domain of endogenous APP and thus
detects sAPPa , Ab and b -stubs besides full-length APP, was
performed identically on uninduced cells to determine baseline
expression. Confocal images, acquired with identical
instrument settings, showed a strong increase in cellular APP
levels (Fig. 3F,G). Therefore, AICD induces not only the
transcription of APP but also results in increased protein levels.
We next analyzed APP expression with western blots of wild-
type HEK293 and clonal lines with different induction times
of AICD expression (Fig. 3H). There was no significant
increase in the levels of full-length APP at 3, 6 and 48 hours
of AICD expression, compared with uninduced cells
(normalized to GAPDH). By contrast, we detected increases in
a - and b -stubs, reaching 2.2-fold (s.e.m.=0.2, n=3) of the levels
seen in uninduced cells after 48 hours of induction of citrine-
AICD expression (Mann-Whitney U, P<0.05, Fig. 3H).
Furthermore, after 48 hours of expression of citrine-AICD we
could detect endogenous AICD in addition to a - and b -stubs.
The increase in a - and b -stubs was also seen in naive HEK293
cells after inhibition of g -secretase with DAPT. Compared with
naive HEK293 we could detect nearly twofold higher levels of
full-length APP and stubs in uninduced AICD-expressing cell
lines. This might be due to leakage of AICD expression with
our inducible system, which is not evident via confocal
microscopy (Fig. 3F) but can be detected in western blots (Fig.
3H).
Jip1 targets AICD to Tip60 whereas X11 traps it to
extranuclear sites
The jun-interacting protein (Jip1) is another APP-adaptor
protein (Matsuda et al., 2001; Scheinfeld et al., 2002b; Taru
et al., 2002a; Taru et al., 2002b) that shows transactivation
activity in the Gal4 system (Scheinfeld et al., 2003). Jip1b is
a splice variant with an insertion of 47 amino acids in the
COOH-terminal phosphotyrosine binding (PTB) domain of
Jip1 (Whitmarsh et al., 1998). Transfection of Jip1b into
AICD-expressing cells reveals an extranuclear localization.
Fig. 3. Fe65 transports AICD to nuclei where it can regulate
transcription. (A) Blocking nuclear export with leptomycin B for 9
hours leads to an accumulation of Fe65 and AICD in nuclei. In cells
co-expressing Fe65 and AICD, leptomycin B caused the formation of
nuclear AICD-containing spots that were never observed in cells
without the cotransfection of Fe65, or in the absence of leptomycin B
(compare Fig. 1A,B). Bar, 10 m m. (B) Leptomycin B (24 hours)
increased fluorescence signal intensity ratios of nuclear versus
extranuclear staining for AICD and Fe65 in co-expressing cells.
Without the expression of Fe65, leptomycin B treatment did not
change the nuclear/extranuclear signal ratio for AICD. (C) Western
blots of nuclear (n) and post-nuclear supernatant (PNS) fractions
from AICD- and Fe65-expressing cells treated with lepomycin B (0
to 24 hours) showed increased nuclear retention of Fe65. The
nuclear/PNS signal ratio for Fe65 increased to 247% after 9 hours
and to 527% after 24 hours, as compared with a 100% baseline.
Marker proteins are 19, 28, 39, 51, 64, 97 and 191 kDa. (D,E) Real-
time PCR of clonal cell lines with and without the induced
expression of citrine-AICD revealed that AICD increased the
expression of APP, BACE and Tip60 (Mann-Whitney U, P<0.05).
AICD did not change the expression of Fe65, Tip60, ADAM10,
PSEN1, or the Notch-effector gene Hes1. The AICD-induced
expression of KAI1 and Gsk3 b was confirmed. All values were
normalized against GAPDH expression levels and expressed as fold
baseline without induction of AICD expression. Data represent
means ± s.e.m. of five experiments, each done in triplicate.
(F,G) Clonal HEK293 grown for 48 hours without (F) or with (G) the
induction of AICD-citrine expression. 6E10-staining for endogenous
APP reveals increased protein levels induced by AICD. Bar, 20 m m.
(H) Whole cell extracts of naive HEK293 and AICD-expressing
clonal cell lines. Western blots were analyzed with antibodies against
the N- or C-terminus of APP, against GFP to detect the citrine-AICD
fusion protein and GAPDH as a loading control. Naive HEK293 (C,
lane 1) were also treated with the g -secretase inhibitor DAPT, which
leads to accumulation of a - and b -stubs (DAPT, lane 2). Clonal
HEK293 were induced for 3, 6 or 48 hours (lane 4 to 6) to express
citrine-AICD. Bar diagram shows densitometric analysis of full-
length APP and a - together with b -stubs from three independent
experiments. Relative protein levels are determined with respect to
uninduced cells (0 hrs).
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Binding of AICD by Jip1b is evident from the clearance of
AICD from the nucleus (Fig. 4A). Surprisingly, when Tip60
is co-expressed Jip1b localizes to nuclear speckles (Fig. 4B).
In contrast to Fe65, the speckles show the same morphology
as Tip60 alone. AICD is also localized to these speckles,
although at lower levels than seen with Fe65, and AICD is still
detected in the cytosol (Fig. 4C). The number of speckles per
nucleus was 10.7 (s.d.=5.1, median=10, n=63 nuclei), which
was significantly lower than spot numbers with Fe65-
containing complexes. From our data we cannot determine
whether the interaction between Tip60 and Jip1b is direct or
indirect via the recruitment of additional endogenous proteins.
When Jip1b was transformed together with the functionally
impaired, NASA-mutated Tip60 (Cao and Südhof, 2001) it
still localized together with Tip60 in speckle-like structures
(not shown).
Cotransformation of X11 a (MINT1), another APP-adaptor
protein (Borg et al., 1996), showed a subcellular distribution
similar to Jip1b, with no signal detected in the nucleus.
Again, the binding of AICD to X11 a led to a clearance of
AICD from the nucleus (Fig. 4D). X11 a has an inhibitory
effect on AICD-mediated transactivation in the Gal4 system
(Biederer et al., 2002). Tip60 did not relocate X11 a to
nuclear spots and no nuclear AICD was detectable (Fig. 4E).
X11 a thus traps AICD in the cytosol and therefore differs
from the effects of Fe65 and Jip1b on nuclear AICD
localization.
Full-length APP-derived AICD translocates to nuclei –
inhibition by g -secretase inhibitors
To verify whether AICD generated from full-length APP also
translocates to the nucleus we expressed APP695-citrine fusion
proteins via the ecdyson-inducible system. The citrine cDNA
was cloned downstream of the C-terminus of APP, either via a
short spacer or a longer spacer coding for a tandem HA tag
(see Materials and Methods). Sixteen hours after the induction
of transgene expression citrine fluorescence was detected in the
perinuclear endoplasmic reticulum and the Golgi complex, and
highly colocalized with the HA tag staining (Fig. 5A).
Furthermore, APP-fluorescence was seen in spots covering the
membrane surface of the soma and all processes. This pattern
resembled the distribution of endogenous APP. No
fluorescence was detected in the nucleus when observing
confocal sections. Cotransformation of Fe65 and Tip60 again
led to the appearance of AICD-citrine fluorescence in nuclear
spots (Fig. 5B). One APP-citrine construct contained a tandem
HA tag preceding the citrine. The HA tag antibody stained APP
in the ER/Golgi and processes, but it failed to label nuclear
AFT-complexes, which were readily detected via the citrine
fluorescence (Fig. 5C). With the formation of nuclear AFT-
complexes, antibody access to the HA tag was obviously
prevented. Owing to the low percentage of cells transformed
by all four constructs (APP, Fe65, Tip60, ecdysone
transactivator), we were not able to immunoprecipitate AICD
from nuclear fractions and test for HA tag staining in western
blots. Nevertheless, using homogenates of transfected cells, we
could detect an approximately 35 kDa band of AICD-2HA-
citrine, which was detected by antibodies against GFP and the
HA-tag in western blots (data not shown). The integrity of the
secretase-generated AICD-HA tag-citrine fusion protein can be
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Fig. 4. APP-interacting proteins Jip1b and
X11a have different effects on nuclear
AICD localization. (A) Extranuclear
localization of Jip1b. Binding of AICD to
Jip1b was associated with decreased nuclear
levels of AICD. (B) Co-expression of Tip60
relocalized Jip1b into nuclear speckles.
(C) Additional co-expression of AICD
resulted in the formation of nuclear AICD-
Jip1-Tip60 (AJT) complexes with a distinct
speckle-like morphology, as compared with
the smaller spherical spots generated by
AFT-complexes. (D) Exclusive extranuclear
localization of X11a . Binding of AICD to
X11a was associated with decreased nuclear
levels of AICD. (E) Co-expression of Tip60
had no effect on the extranuclear
localization of either X11a or AICD. Bar,
10 m m.
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inferred from the fact that citrine alone was not targeted to
nuclear spots containing Fe65 and Tip60 (data not shown). As
the AICD sequence is responsible for localization to nuclear
spots where citrine fluorescence is observable, the connecting
HA tag must be intact. Fig. 5D shows another cell with the HA
tag of APP stained with Cy5 to enable FRET measurements.
Again, the HA tag-staining detected APP in the soma and
processes, but failed to label nuclear AFT-complexes.
Excitation of CFP-Tip60 resulted in sensitized emission from
APP-derived AICD-citrine, localized in nuclear spherical
spots. Together with the failure of anti-HA antibody staining
of nuclear spots, this shows the close molecular interaction in
AFT-complexes.
Sequential cleavage of transmembrane APP by secretases
liberates AICD from the membrane. Inhibition of g -secretase
by L-685,458 (Shearman et al., 2000) or DAPT (Geling et al.,
2002; Sastre et al., 2001) completely abolished the formation
of nuclear AICD spots from APP-citrine fusion proteins. None
of the cells co-expressing APP, Fe65 and Tip60 showed nuclear
AICD localization (n=15 cells with L-685,458, n=27 cells with
DAPT). In cells with low-to-medium levels of APP expression
Fe65 localized to spherical nuclear spots together with Tip60
(n=25 cells), despite the inhibition of nuclear AICD
localization (Fig. 6A, upper cell and 6B). The nuclear
localization of Fe65 was prevented in cells with high
APP expression (n=17 cells) (Fig. 6A, lower cell);
instead it closely resembled the distribution of APP.
Without the inhibition of g -secretase the formation of
nuclear spots with spherical AFT-complexes was seen
in 69 out of 76 cells expressing all three proteins (Fig.
6C).
Formation of nuclear AFT- and AJT-complexes in
differentiated neuroblastoma cells
Transient transfections were also done in SH-SY5Y
cells differentiated for 10 days with retinoic acid and
BDNF. In these cells Fe65 was already concentrated in
the nucleus without the addition of Tip60 (Fig. 7A). Co-
expression of AICD, Fe65 and Tip60 again led to the
formation of spherical nuclear spots of AFT-complexes
(Fig. 7B). As seen in HEK293 cells, Jip1b and X11 a
had an extranuclear localization leading to a similar
localization of AICD. Co-expression of Tip60 resulted
in the relocalization of Jip1 and AICD to nuclear AJT-
complexes, with speckle-like morphology (Fig. 7C).
Finally, co-expression of full-length APP with Fe65 and
Tip60 also resulted in the appearance of AICD in
nuclear spots (Fig. 7D). Thus, cells differentiated into a
neuronal phenotype also show the formation of AFT-
and AJT-complexes in the nuclear compartment.
Fig. 5. AICD derived from full-length APP translocates to the
nucleus and generates AFT-complexes. (A) Cells expressing
APP fused to a C-terminal HA tag (red) followed in tandem
by citrine (yellow). As expected, full-length APP was
localized in the ER/Golgi and in vesicles in the processes and
somata, but not in nuclei. Staining of APP with antibodies
directed against the C-terminal HA tag colocalized with
citrine fluorescence in extranuclear localizations. Confocal
xz-scans through nuclei confirmed the extranuclear
localization of full-length APP. (B) Cells co-expressing full-
length APP together with Fe65 and Tip60 formed nuclear
AFT-complexes with spherical spot morphology. (C) In
contrast to the extranuclear colocalization of HA antibody
staining with citrine fluorescence, HA antibodies failed to
detect the nuclear AFT-complexes that emitted strong citrine
fluorescence signals. (D) FRET measurements showed close
molecular association of APP-derived AICD with Tip60 in
nuclear AFT-complexes. Antibodies against the C-terminal
HA tag of APP, stained with Cy5 (blue), consistently failed to
detect AICD in AFT-complexes. Bar, 10 m m in A to C, 20 m m
in D upper row and 5 m m in D lower row.
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Discussion
The results of this study show that the APP-binding adaptor
proteins Fe65, Jip1b and X11a (MINT1) differentially regulate
the formation of nuclear AICD-containing complexes. Our
data also establish that AICD increased the transcription of the
AICD-effector genes APP, BACE and Tip60, in addition to
GSK3b and KAI1.
Regulation of nuclear AICD targeting
To characterize the cellular trafficking of the APP-derived
AICD generated by g -secretase, we expressed citrine-AICD
fusion proteins representing the S3-cleaved APP C-terminus by
using an ecdyson-inducible expression system. Co-expression
of AICD-adaptor proteins showed that Fe65 or Jip1b targeted
the AICD to specific nuclear loci, whereas X11 a trapped it in
the cytosol. Blocking nuclear export showed that Fe65 is
actively cycled between nuclear and cytosolic compartments
and can transport bound AICD. Within nuclei Fe65 or Jip1b
docked with bound AICD to the histone acetylase Tip60 and
formed AICD-containing AFT- or AJT-complexes with clearly
distinctive morphologies. Nuclear AFT-complexes appeared in
multiple homogenous spherical spots, whereas AJT-complexes
occupied a significantly lower number of speckle-like
structures. The different morphology of the spherical spots
containing AFT-complexes compared with the speckle-like
structures containing the AJT-complexes suggests that they
might involve the regulation of different sets of genes
associated with different cellular functions. The precise
functions of AFT- and AJT-complexes are unknown, but our
measurements indicated that the nuclear structures containing
these complexes are very large, consistent with the possibility
that they contain additional proteins or DNA required for
transcriptional activity. Both FRET and IP analyses illustrated
the close molecular interaction of AICD with Tip60 in the
nuclear complexes. Additional studies are required to
determine whether they represent sites of active transcription.
The differential effects on nuclear targeting of AICD are
consistent with data from yeast Gal4 transactivation
experiments that showed transactivation activity for AICD
together with either Fe65 or Jip1b, and inhibitory activities of
X11a (Cao and Sudhof, 2001; Biederer et al., 2002; Scheinfeld
et al., 2003). The nuclear translocation of intracellular domains
liberated from membranes by g -secretase is an emerging
concept underscored by the fact that both Notch and N-
cadherin use this pathway for signaling from the cell surface
to the nucleus to regulate transcription (Schroeter et al., 1998;
Marambaud et al., 2003).
Full-length APP functions in nuclear signaling
Our results show that the AICD generated from full-length
APP by g -cleavage at the plasma membrane (Cupers et al.,
2001b) can be transported to the nucleus by Fe65, and docked
onto Tip60 both in HEK293 and differentiated SH-SY5Y cells,
suggesting the possibility that APP also functions in nuclear
signaling in neuronal cells. Neurons express high endogenous
levels of APP, Fe65 and Tip60 (Card et al., 1988; Hu et al.,
1999; Ran and Pereira-Smith, 2000; Russo et al., 1998; Shivers
et al., 1988), and neurons process APP to form AICD. It is
therefore conceivable that neurons can form AFT- and AJT-
complexes. Despite the fact that recent experiments claimed
the presence of intranuclear AICD in neurons (Kimberly et al.,
2001), many previous attempts to localize AICD
immunohistochemically in nuclei of neuronal cells or brain
tissue sections failed. The reasons for this absence of antibody
staining could involve sensitivity issues, as well as the short
half-life of free cytosolic AICD, but our results offer an
alternative explanation. Our APP-derived AICD with a tandem
HA-citrine tag allowed us to localize nuclear AICD via the
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Fig. 6. Pharmacological inhibition of g -
secretase processing of APP blocks the
formation of nuclear AFT-complexes.
(A,B) The g -secretase inhibitors DAPT
and L-685,458 prevented the localization
of APP-derived AICD into nuclear AFT-
complexes. In cells with lower APP
expression Fe65 was targeted to nuclear
spots, whereas in cells with high levels of
APP, Fe65 was retained at extranuclear
localizations of APP including the
ER/Golgi and vesicular structures.
(C) Control experiment in the absence of
g -secretase inhibitors confirmed the
formation of APP-derived nuclear AFT-
complexes. Bar, 10 m m.
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direct citrine fluorescence, while antibodies against the HA tag
at the C-terminus clearly bound to AICD in the cytoplasm, but
not to the nuclear AFT-complexes. These data suggest that
nuclear complex formation with Tip60 and Fe65 prevents
antibody access to AICD. Therefore, either more elaborate
protocols for tissue permeabilization or transgenic approaches
with fluorescent APP fusion proteins are required to show
nuclear AICD complexes in vivo.
AICD-dependent regulation of gene expression
To test the hypothesis that AICD controls genes involved in the
regulation of cellular levels of APP, we analyzed transcripts
encoding APP upon induced expression of AICD. By using
clonal cell lines with inducible expression constructs, we
generated two mRNA populations differing only in the
expression of AICD and its putative downstream effector
genes. These experiments clearly showed that AICD
upregulated the expression of the APP genes as part of a
positive feedback mechanism, by which APP senses its own
endoproteolysis and upregulates its expression to replenish
full-length APP. We next tested the hypothesis that AICD
regulates the expression of enzymes involved in its generation
and established that AICD upregulates the gene encoding the
b -site APP cleaving enzyme (BACE), but not the g -secretase-
complex protein PSEN1 or ADAM10, one of the proposed a -
secretases (Vassar et al., 1999; Edbauer et al., 2003; Lammich
et al., 1999). To be functionally meaningful for nuclear
signaling, this positive feedback amplification of AICD should
be associated with increased levels of the components of the
nuclear AFT-complex. Therefore, in the same cells we
analyzed the expression of Tip60 and Fe65 and found that
AICD also increased the expression of Tip60. These data could
explain the recent observation of increased Tip60 in APP
transgenic mice (Baek et al., 2002). In the same cell lines, we
were able to confirm the previously reported AICD-dependent
induction of KAI-1 and GSK3b (Baek et al., 2002; Kim et al.,
2003). Together, these results establish that APP not only
regulates its own expression but also the expression of several
genes involved in its processing and cellular function.
Importantly, the NICD-effector gene Hes1 of the Notch
signaling pathway, which is also regulated by g -secretase, was
unaffected by AICD. From these data we cannot exclude the
possibility that the effect of AICD on transcription is indirect,
Fig. 7. Formation of APP-derived nuclear AFT- and AJT-complexes in
differentiated human neuroblastoma cells. (A) Nuclear and cytoplasmic
localization of Fe65 expressed in SH-SY5Y cells differentiated with retinoic
acid and BDNF. (B) Co-expression of Tip60, Fe65 and AICD led to the
formation of nuclear AFT-complexes with spherical spot morphology. (C) Co-
expression of Tip60, Jip1b and AICD led to the formation of nuclear AJT-
complexes with speckle-like morphology. (D) AICD derived from full-length
APP is targeted to nuclear AFT-complexes with spherical spot morphology.
The inset shows a higher magnification of the soma, with a lower exposure to
visualize nuclear spots,
which are over-exposed
in the overview. Bar in
A: 20 m m for A,D; 10
m m for B,C,D inset.
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i.e. by influencing the nuclear signaling of other pathways
controlling transcription. Nevertheless, Cao and Südhof (Cao
and Südhof, 2001) have shown a transcription-activating
activity for AICD bound to Fe65, and we show the
colocalization of AICD together with Fe65 and Tip60 in
discrete nuclear spots. If the average number of 32 AFT-
complex-containing nuclear spots and 11 AJT-complex-
containing speckles are related to the number of AICD-
regulated genes, it is probable that more than the above genes
are regulated by APP signaling.
The increase in APP transcripts is accompanied by increased
levels of protein. In particular, C-terminal stubs were
significantly increased in parallel to the induced expression of
AICD. The fact that steady-state levels of full-length APP did
not increase significantly in this condition is probably related
to the observed concomitant increase in BACE expression,
which is expected to increase the turnover of full-length APP;
a similar mechanism may be involved in the observed increased
generation of a -stubs. Together, these data are consistent with
the idea that the steady-state levels of APP are maintained at
constant cellular concentrations under physiological
conditions. The life cycle of APP therefore encompasses a
feedback mechanism of synthesis, subcellular sorting,
proteolytic cleavages and finally nuclear signaling and
transcriptional activation of APP by AICD. The additional
cellular effects of the AICD-induced increase in APP turnover
remain to be determined.
Role of g -secretase processing in nuclear signaling
The nuclear translocation of intracellular domains liberated
from membranes by g -secretase is an emerging concept for
signaling from the cell surface to the nucleus, to regulate gene
transcription. The intracellular domains cleaved from the
membrane-bound precursors Notch, ErbB4, Neuregulin1, LRP,
N-cadherin APLP1, APLP2 and APP translocate to nuclei, and
transactivation activity was shown for Notch, Delta 1,
Neuregulin1, N-cadherin, APLP1, APLP2 and APP (Bao et al.,
2003; Ikeuchi and Sisodia, 2003; Kimberly et al., 2001;
Kinoshita et al., 2002; Kinoshita et al., 2003; Marambaud et
al., 2003; May et al., 2002; Ni et al., 2001; Scheinfeld et al.,
2002a; Schroeter et al., 1998; Walsh et al., 2003). Besides the
g -secretase complex similar adaptor-proteins are involved in
nuclear signaling; for example, LRP can bind Fe65 via a
different phosphotyrosine-interacting domain than AICD
(Kinoshita et al., 2001), and binding of numb by APP
influences Notch signaling (Roncarati et al., 2002). Finally, in
the nucleus the histone acetylase Tip60 is involved in
chromatin remodeling for a variety of signals including STAT-
3 (signal transducer and activator of transcription-3), CREB,
c-myc, nuclear hormone receptors (Brady et al., 1999; Frank
et al., 2003; Gaughan et al., 2001; Xiao et al., 2003). The LRP-
ICD generated by g -secretase cleavage was recently shown to
also localize with Tip60 in nuclear speckles (Kinoshita et al.,
2003). Together, these findings suggest that g -secretase
processing of membrane proteins is involved in multiple
signaling pathways, and that cross-talk of these pathways by
means of the common interaction partners could affect APP-
dependent nuclear signaling. In addition, these observations
suggest that AICD-regulated genes are a subset of a much
larger group of genes controlled by g -secretase processing.
In summary, our data provide strong evidence in favor of
nuclear signaling functions of AICD and they show that these
functions are regulated by the APP-adaptor proteins Fe65,
Jip1b and X11a , as well as the nuclear docking protein Tip60.
AICD regulates the expression of its precursor APP and
therefore acts as a signal of APP cleavage, leading to the
replenishment of full-length APP levels. In the light of these
functions of AICD, and the growing list of g -secretase-
substrates that signal to the nucleus, the therapeutic use of g -
secretase inhibitors needs to be carefully evaluated.
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